2021 Q1 Form 10-Q Financial Statement

#000162828021009595 Filed on May 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $521.1K $84.30K
YoY Change 518.1% -76.85%
Cost Of Revenue $6.225M $1.748M
YoY Change 256.14% 25.07%
Gross Profit -$5.704M -$1.664M
YoY Change 242.87% 60.99%
Gross Profit Margin -1094.74% -1973.52%
Selling, General & Admin $6.886M $5.566M
YoY Change 23.72% 166.19%
% of Gross Profit
Research & Development $3.864M $1.902M
YoY Change 103.11% 39.64%
% of Gross Profit
Depreciation & Amortization $311.1K $171.8K
YoY Change 81.15% 77.65%
% of Gross Profit
Operating Expenses $10.75M $7.468M
YoY Change 43.94% 116.27%
Operating Profit -$16.45M -$8.267M
YoY Change 99.03% 84.26%
Interest Expense $13.50M $13.02M
YoY Change 3.69% 632.46%
% of Operating Profit
Other Income/Expense, Net -$136.6M $860.0K
YoY Change -15983.72%
Pretax Income -$138.1M $4.757M
YoY Change -3004.1% -175.93%
Income Tax -$17.63M $0.00
% Of Pretax Income 0.0%
Net Earnings -$120.5M $4.757M
YoY Change -2633.42% -175.93%
Net Earnings / Revenue -23127.24% 5642.58%
Basic Earnings Per Share -$0.98 $0.07
Diluted Earnings Per Share -$1.04 $0.06
COMMON SHARES
Basic Shares Outstanding 122.6M shares 68.47M shares
Diluted Shares Outstanding 128.3M shares 83.77M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $399.0M $16.80M
YoY Change 2275.0% 500.0%
Cash & Equivalents $205.1M $16.82M
Short-Term Investments $194.0M
Other Short-Term Assets $36.60M $4.800M
YoY Change 662.5% 140.0%
Inventory $30.67M $2.631M
Prepaid Expenses
Receivables $1.142M $48.83K
Other Receivables $0.00 $100.0K
Total Short-Term Assets $467.4M $24.29M
YoY Change 1823.95% 211.47%
LONG-TERM ASSETS
Property, Plant & Equipment $12.35M $6.769M
YoY Change 82.49% 32.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $13.10M
YoY Change -100.0%
Other Assets
YoY Change
Total Long-Term Assets $12.35M $19.95M
YoY Change -38.09% 276.45%
TOTAL ASSETS
Total Short-Term Assets $467.4M $24.29M
Total Long-Term Assets $12.35M $19.95M
Total Assets $479.8M $44.25M
YoY Change 984.3% 237.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.373M $3.062M
YoY Change 108.16% -14.95%
Accrued Expenses $5.922M $3.388M
YoY Change 74.81% -13.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $20.16M
YoY Change -100.0%
Total Short-Term Liabilities $17.55M $39.29M
YoY Change -55.33% 73.09%
LONG-TERM LIABILITIES
Long-Term Debt $182.2M $7.430M
YoY Change 2352.22% -11.55%
Other Long-Term Liabilities $207.0K
YoY Change
Total Long-Term Liabilities $207.0K $7.430M
YoY Change -97.21% -11.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.55M $39.29M
Total Long-Term Liabilities $207.0K $7.430M
Total Liabilities $204.2M $46.72M
YoY Change 336.96% 50.23%
SHAREHOLDERS EQUITY
Retained Earnings -$229.5M -$174.0M
YoY Change 31.88%
Common Stock $123.3K $69.49K
YoY Change 77.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $275.6M -$22.00M
YoY Change
Total Liabilities & Shareholders Equity $479.8M $44.25M
YoY Change 984.3% 237.76%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$120.5M $4.757M
YoY Change -2633.42% -175.93%
Depreciation, Depletion And Amortization $311.1K $171.8K
YoY Change 81.15% 77.65%
Cash From Operating Activities -$34.90M -$7.823M
YoY Change 346.18% 35.61%
INVESTING ACTIVITIES
Capital Expenditures $1.265M $464.0K
YoY Change 172.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.265M -$464.0K
YoY Change 172.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $14.22K $243.0K
YoY Change -94.15% -96.58%
NET CHANGE
Cash From Operating Activities -$34.90M -$7.823M
Cash From Investing Activities -$1.265M -$464.0K
Cash From Financing Activities $14.22K $243.0K
Net Change In Cash -$36.15M -$8.044M
YoY Change 349.47% -702.45%
FREE CASH FLOW
Cash From Operating Activities -$34.90M -$7.823M
Capital Expenditures $1.265M $464.0K
Free Cash Flow -$36.17M -$8.287M
YoY Change 336.46% 43.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001425287
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45140
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-37673
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
WORKHORSE GROUP INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1394771
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Commerce Drive
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Loveland
CY2021Q1 dei City Area Code
CityAreaCode
513
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
360-4704
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2021Q1 dei Trading Symbol
TradingSymbol
WKHS
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
123260319 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
205074876 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46817825 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
194411242 USD
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
193950792 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
0 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1141799 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1132164 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
30671406 USD
CY2021Q1 wkhs Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
0 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
15467012 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36572534 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32759216 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
467411407 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
290587459 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12351789 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11398166 USD
CY2020Q4 wkhs Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
330556744 USD
CY2021Q1 us-gaap Assets
Assets
479763196 USD
CY2020Q4 us-gaap Assets
Assets
632542369 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6373149 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4790763 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5922315 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5995302 USD
CY2021Q1 wkhs Warranty Liability
WarrantyLiability
5255043 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 wkhs Warranty Liability
WarrantyLiability
5400000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1411000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
17550507 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17597065 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
207040 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
207040 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4201438 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
21833930 USD
CY2021Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
182200000 USD
CY2020Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
197700000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
204158985 USD
CY2020Q4 us-gaap Liabilities
Liabilities
237338035 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123254853 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123254853 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121922532 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121922532 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
123255 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
121923 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
505017758 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
504112442 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229536802 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109030031 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
275604211 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
395204334 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
479763196 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
632542369 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
521060 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84300 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
6225299 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
1747975 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
-5704239 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
-1663675 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6885830 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5565787 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3863715 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1902236 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
10749545 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
7468023 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-136605952 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
864900 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-153059736 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120506771 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8266798 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14920473 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13023489 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138139263 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4756691 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17632492 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122633856 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68465759 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128301184 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83768820 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120506771 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-120506771 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5856691 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-34913110 USD
CY2020Q1 wkhs Stock Options And Warrants Exercised
StockOptionsAndWarrantsExercised
243000 USD
CY2020Q1 wkhs Preferred Stock Dividends Common Stock Issued Value
PreferredStockDividendsCommonStockIssuedValue
500000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5193552 USD
CY2020Q1 wkhs Stock Issued During Period Value Interest On Convertible Notes
StockIssuedDuringPeriodValueInterestOnConvertibleNotes
264212 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
859027 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1100000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-21996628 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
395204334 USD
CY2021Q1 wkhs Stock Options And Warrants Exercised
StockOptionsAndWarrantsExercised
14220 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
892428 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120506771 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
275604211 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120506771 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
311144 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
171761 USD
CY2021Q1 wkhs Tooling Expense
ToolingExpense
0 USD
CY2020Q1 wkhs Tooling Expense
ToolingExpense
353786 USD
CY2021Q1 wkhs Amortization Of Discount On Series Preferred Stock
AmortizationOfDiscountOnSeriesPreferredStock
0 USD
CY2020Q1 wkhs Amortization Of Discount On Series Preferred Stock
AmortizationOfDiscountOnSeriesPreferredStock
377583 USD
CY2021Q1 wkhs Change In Fair Value Convertible Notes
ChangeInFairValueConvertibleNotes
15500000 USD
CY2020Q1 wkhs Change In Fair Value Convertible Notes
ChangeInFairValueConvertibleNotes
5136448 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9145000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-136605952 USD
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
864900 USD
CY2021Q1 wkhs Payments For Preferred Stock Dividends Noncash
PaymentsForPreferredStockDividendsNoncash
0 USD
CY2020Q1 wkhs Payments For Preferred Stock Dividends Noncash
PaymentsForPreferredStockDividendsNoncash
-500000 USD
CY2021Q1 wkhs Interest On Convertible Note Paid In Common Stock
InterestOnConvertibleNotePaidInCommonStock
0 USD
CY2020Q1 wkhs Interest On Convertible Note Paid In Common Stock
InterestOnConvertibleNotePaidInCommonStock
264212 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
892428 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
859027 USD
CY2021Q1 wkhs Inventory Adjustments Net
InventoryAdjustmentsNet
361717 USD
CY2020Q1 wkhs Inventory Adjustments Net
InventoryAdjustmentsNet
0 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1411000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
17632492 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
CY2021Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
9635 USD
CY2020Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
35393 USD
CY2021Q1 wkhs Increase Decreasein Inventory
IncreaseDecreaseinInventory
14842677 USD
CY2020Q1 wkhs Increase Decreasein Inventory
IncreaseDecreaseinInventory
832678 USD
CY2021Q1 wkhs Increase Decrease In Prepaid Deferred Expenses And Other Assets1
IncreaseDecreaseInPrepaidDeferredExpensesAndOtherAssets1
3813318 USD
CY2020Q1 wkhs Increase Decrease In Prepaid Deferred Expenses And Other Assets1
IncreaseDecreaseInPrepaidDeferredExpensesAndOtherAssets1
-55165 USD
CY2021Q1 wkhs Increase Decrease In Accounts Payable And Accrued Liabilities1
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1
1509399 USD
CY2020Q1 wkhs Increase Decrease In Accounts Payable And Accrued Liabilities1
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1
1552484 USD
CY2021Q1 wkhs Increase Decrease In Warranty
IncreaseDecreaseInWarranty
144957 USD
CY2020Q1 wkhs Increase Decrease In Warranty
IncreaseDecreaseInWarranty
699094 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34903644 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7822804 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1264767 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
463985 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1264767 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-463985 USD
CY2021Q1 wkhs Exercise Of Warrants And Options And Restricted Share Award Activity
ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity
14220 USD
CY2020Q1 wkhs Exercise Of Warrants And Options And Restricted Share Award Activity
ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity
243000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14220 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36154191 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8043789 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
241229067 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24868416 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
205074876 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16824627 USD
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to the prior year condensed consolidated financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operations or stockholders' equity.</span></div>
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
28252565 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
16759232 USD
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
4495320 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
422176 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
277053 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
277419 USD
CY2021Q1 us-gaap Inventory Gross
InventoryGross
33024938 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
17458827 USD
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2353532 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1991815 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
30671406 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
15467012 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
521060 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84300 USD
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P7Y
CY2020Q1 wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividend
300000 shares
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
400000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000.0 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6300000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8000000.0 shares
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
892428 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
859027 USD
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4200000 USD
CY2021Q1 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-17600000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-120506771 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2021Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2000000 USD
CY2020Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 USD
CY2021Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-15500000 USD
CY2020Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-134006771 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
4756691 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122633856 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68465759 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128301184 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83768820 shares

Files In Submission

Name View Source Status
0001628280-21-009595-index-headers.html Edgar Link pending
0001628280-21-009595-index.html Edgar Link pending
0001628280-21-009595.txt Edgar Link pending
0001628280-21-009595-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wkhs-20210331.htm Edgar Link pending
wkhs-20210331.xsd Edgar Link pending
wkhs-20210331xexx311.htm Edgar Link pending
wkhs-20210331xexx312.htm Edgar Link pending
wkhs-20210331xexx321.htm Edgar Link pending
wkhs-20210331xexx322.htm Edgar Link pending
wkhs-20210331_cal.xml Edgar Link unprocessable
wkhs-20210331_def.xml Edgar Link unprocessable
wkhs-20210331_htm.xml Edgar Link completed
wkhs-20210331_lab.xml Edgar Link unprocessable
wkhs-20210331_pre.xml Edgar Link unprocessable